Discontinued — last reported Q4 '21
Vistra Short-Term Borrowings decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $1.36B to $0.00. This is a positive signal — lower values indicate better performance for this metric.
High levels may indicate a reliance on short-term credit markets for operational cash flow, which can increase liquidity risk.
Short-term borrowings consist of debt obligations that are due within one year, excluding the current portion of long-te...
Varies by industry; pharmaceutical firms often maintain access to short-term credit for operational flexibility.
short_term_borrowings| Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.30B | $0.00 | $650.00M | $0.00 | $0.00 | $0.00 | $0.00 | $500.00M | $0.00 | $1.34B | $1.36B | $861.00M | $1.80B | $0.00 |
| QoQ Change | — | — | -100.0% | — | -100.0% | — | — | — | — | -100.0% | — | +1.5% | -36.5% | +109.1% | -100.0% |
| YoY Change | — | — | — | — | — | -100.0% | — | -100.0% | — | — | — | +171.0% | — | +34.8% | -100.0% |